Literature DB >> 6875846

Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.

J D Johnson, D A Fugman.   

Abstract

Ca++ antagonist drugs (also known as Ca++ channel blockers) and the calmodulin antagonists trifluoperazine (TFP) and W-7 [N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide] were capable of half-maximally relaxing porcine coronary segments at 1.5 X 10(-10) M for felodipine, 6.5 X 10(-8) M for verapamil, 2.6 X 10(-7) M for diltiazem, 7 X 10(-7) M for prenylamine, 7 X 10(-6) M for TFP and 45 X 10(-6) M for W-7. Their correspondent binding to calmodulin was half-maximal at 2.8 X 10(-6), 30 X 10(-6), 80 X 10(-6), 5 X 10(-7), 5.0 X 10(-6) and 11 X 10(-6) M, respectively. Only prenylamine, TFP and W-7 were capable of relaxing coronaries over the same concentration range in which they bind to calmodulin. The relaxations produced by these calmodulin antagonists and prenylamine could not be overcome by contractile agonists which release Ca++ from internal stores (histamine and serotonin), whereas the relaxations produced by felodipine, verapamil and diltiazem were readily reversed by either of these agonists. This is consistent with TFP and W-7 and to some degree prenylamine-inducing vasodilation by calmodulin antagonism and with felodipine, verapamil and diltiazem vasodilating through Ca++ antagonism of Ca++ channels at the level of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6875846

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Inhibition of endothelium-dependent smooth muscle relaxation by calmodulin antagonists.

Authors:  G Weinheimer; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

Review 2.  Modulation of calcium sensitivity in guinea pig taenia coli: skinned fiber studies.

Authors:  J C Rüegg; G Pfitzer
Journal:  Experientia       Date:  1985-08-15

Review 3.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

4.  Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

5.  Fendiline inhibits L-type calcium channels in guinea-pig ventricular myocytes: a whole-cell patch-clamp study.

Authors:  O Tripathi; W Schreibmayer; H A Tritthart
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

6.  Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.

Authors:  E A Bernstein; F R Eberli; A M Silverman; G L Horowitz; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

7.  Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery.

Authors:  S Illiano; T Nagao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.

Authors:  M Spedding; C Berg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

9.  Kinetic modulation of guinea-pig cardiac L-type calcium channels by fendiline and reversal of the effects of Bay K 8644.

Authors:  W Schreibmayer; O Tripathi; H A Tritthart
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

Review 10.  Calcium antagonists and exercise performance.

Authors:  W Kindermann
Journal:  Sports Med       Date:  1987 May-Jun       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.